Research study Program year 2023 Source: CMS Open Payments

A Phase 23 Randomized Doubleblind Doubledummy Placebo Controlled Study to Evaluate the Safety and Efficacy of 2 Regimens of Orally Administered PF 07321332Ritonavir in Preventing Symptomatic Sarscov2 Infection in Adult Household Contacts of An Individual With Symptomatic Covid19

Research payments

$43,442,968

1,253 payments

Through program year 2023, $43,442,968 in research payments was reported against A Phase 23 Randomized Doubleblind Doubledummy Placebo Controlled Study to Evaluate the Safety and Efficacy of 2 Regimens of Orally Administered PF 07321332Ritonavir in Preventing Symptomatic Sarscov2 Infection in Adult Household Contacts of An Individual With Symptomatic Covid19, across 1,253 payments, paid by Pfizer Inc..

Paid by: Pfizer Inc.
ClinicalTrials.gov: No trial number was reported for this study

By program year

3 rows

Year	Kind	Amount	Payments
2023	Research	$898,675	40
2022	Research	$34,541,582	677
2021	Research	$8,002,710	536

Breakdown

Who paid Research payments · program years 2021–2023

Pfizer Inc. $43,442,968 1,253 payments

Who received the money Research payments · program years 2021–2023

Beautiful Minds Medical Center LLC Organisation paid for research $6,460,804 24 payments
Elias Research Associates LLC Organisation paid for research $5,624,925 91 payments
Elias research AssociatesLLC Organisation paid for research $4,193,560 24 payments
Ariel Santos Organisation paid for research $3,249,941 20 payments
Entrust Clinical Research LLC Organisation paid for research $2,883,763 23 payments
Clinical Trial Source LLC Organisation paid for research $2,341,759 30 payments
Angels Clinical Research Institute INC Organisation paid for research $1,866,013 18 payments
Mplusm Consulting LLC Organisation paid for research $1,550,746 16 payments
USPA Advance Concept Medical Research GroupLLC Organisation paid for research $1,526,879 23 payments
Omega Research Orlando LLC Organisation paid for research $1,299,269 32 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.

Cite this record

“A Phase 23 Randomized Doubleblind Doubledummy Placebo Controlled Study to Evaluate the Safety and Efficacy of 2 Regimens of Orally Administered PF 07321332Ritonavir in Preventing Symptomatic Sarscov2 Infection in Adult Household Contacts of An Individual With Symptomatic Covid19”, Who Paid My Doc, citing CMS Open Payments, program year 2023. https://www.whopaidmydoc.com/research-studies/a-phase-23-randomized-doubleblind-doubledummy-placebo-controlled-study-to-evaluate-the-safety-and-efficacy-of-2-regimens-of-orally-administered-pf-07321332ritonavir-in-preventing-symptomatic-sarscov2-infection-in-adult-household-contacts-of-an-individual-with-symptomatic-covid19-168354841

Figures here may be reproduced with attribution and a link — see for journalists and researchers.